Next report date
Report period
Q2 2024
EPS estimate
−0.26USD
Revenue estimate
—
−85.90 MUSD
100.51 M
Om Viking Therapeutics, Inc.
Sektor
Bransch
VD
Brian Lian
Webbplats
Huvudkvarter
San Diego
Employees (FY)
27
Grundat
2012
FIGI
BBG00LJZ4457
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
